4Panteghini M. IFCC Committee on Standardization of Markers of Cardiac Damage: premises and project presentation[J]. Clin Chem Lab Med, 1998,36: 887-893.
5Panteghini M, Apple FS, Christenson RH, et al. Proposal from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD) : Recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes[J]. Scan J Clin Lab Invest, 1999,59 : 103-112.
6Dati F, Panteghini M, Apple FS, et al. Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage ( C-SMCD ) : Strategies and concepts on standardization of cardiac marker assyas[J]. Scand J Clin Lab Invest, 1999,59:113-123.
7Panteghini M, Apple FS, Christenson RH, et al. Use of biochemical markers in acute coronary syndromes.IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage[J]. Clin Chem Lab Med, 1999,37:687-693.
8Panteghini M, Gerhardt W, Apple FS, et al. Quality specifications for cardiac troponin assays. International Federation of Clinical Chemistry and Laboratory Medicine(IFCC). IFCC Scientific Division Committee on Standardization of Markers of Cardiac Damage[ J ].Clin Chem Lab Med, 2001,39:174-178.
9Wu AHB, Apple FS, Gibler WB, et al. National Academy of Clinical Biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases [J ]. Clin Chem,1999,45 : 1104-1121.
10The Joint European Society of Cardiology/American College Cardiology Committee. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College Cardiology Committee for the redefinition of myocardial infarction[S]. J Am Coll Cardial, 2000,36-959-969.
